These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 20088747)
1. Budesonide/formoterol dry powder in asthma: an option for control as maintenance and reliever therapy. Santus P; Giovannelli F; Di Marco F; Centanni S Expert Opin Pharmacother; 2010 Feb; 11(2):257-67. PubMed ID: 20088747 [TBL] [Abstract][Full Text] [Related]
2. Safety of budesonide/formoterol maintenance and reliever therapy in asthma trials. Sears MR; Radner F Respir Med; 2009 Dec; 103(12):1960-8. PubMed ID: 19815402 [TBL] [Abstract][Full Text] [Related]
3. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma. O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333 [TBL] [Abstract][Full Text] [Related]
4. Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma. Pilcher J; Patel M; Smith A; Davies C; Pritchard A; Travers J; Black P; Weatherall M; Beasley R; Harwood M; Respirology; 2014 Aug; 19(6):842-51. PubMed ID: 24889937 [TBL] [Abstract][Full Text] [Related]
5. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma. Buhl R; Vogelmeier C Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896 [TBL] [Abstract][Full Text] [Related]
6. Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma. McCormack PL; Lyseng-Williamson KA Drugs; 2007; 67(16):2407-31. PubMed ID: 17983258 [TBL] [Abstract][Full Text] [Related]
7. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma]. Korn S; Vogelmeier C; Buhl R Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216 [TBL] [Abstract][Full Text] [Related]
8. Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study. van Schayck OC; Haughney J; Aubier M; Selroos O; Ekström T; Ostinelli J; Buhl R Respir Med; 2012 Feb; 106(2):189-96. PubMed ID: 22119455 [TBL] [Abstract][Full Text] [Related]
9. Budesonide/formoterol in the treatment of asthma. Hodgson D; Mortimer K; Harrison T Expert Rev Respir Med; 2010 Oct; 4(5):557-66. PubMed ID: 20923335 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189 [TBL] [Abstract][Full Text] [Related]
11. [Budesonide/formoterol maintenance and reliever therapy: an effective and easy approach to asthma management]. Mungan D Tuberk Toraks; 2009; 57(1):93-108. PubMed ID: 19533446 [TBL] [Abstract][Full Text] [Related]
12. Budesonide/formoterol maintenance and reliever therapy versus conventional best standard treatment in asthma in an attempted 'real life' setting. Søes-Petersen U; Kava T; Dahle R; Lei Y; Dam N Clin Respir J; 2011 Jul; 5(3):173-82. PubMed ID: 21679353 [TBL] [Abstract][Full Text] [Related]
13. Improvement of asthma therapy by a novel budesonide multidose dry powder inhaler. Möller M; Fritsche D; Rivera D; Libertus H Arzneimittelforschung; 2003; 53(8):562-7. PubMed ID: 13677246 [TBL] [Abstract][Full Text] [Related]
14. Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation. Miller E; FitzGerald JM Can J Clin Pharmacol; 2008; 15(2):e165-76. PubMed ID: 18515918 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of adjustable maintenance dosing with budesonide/formoterol turbuhaler compared with traditional fixed doses in bronchial asthma: a multi-centre Nigerian study. Ige OM; Ohaju-Obodo JO; Chukwu C; Peters EJ; Okpapi J; Chukwuka C Afr J Med Med Sci; 2010 Sep; 39(3):165-72. PubMed ID: 21416785 [TBL] [Abstract][Full Text] [Related]
16. Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. Busse WW; Shah SR; Somerville L; Parasuraman B; Martin P; Goldman M J Allergy Clin Immunol; 2008 Jun; 121(6):1407-14, 1414.e1-6. PubMed ID: 18455221 [TBL] [Abstract][Full Text] [Related]
17. The use of inhaled formoterol in the treatment of asthma. Berger WE Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777 [TBL] [Abstract][Full Text] [Related]
18. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler. Berger WE; Noonan MJ J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601 [TBL] [Abstract][Full Text] [Related]
19. Inhalation devices for long-acting beta2-agonists: efficiency and ease of use of dry powder formoterol inhalers for use by patients with asthma and COPD. Molimard M; Till D; Stenglein S; Singh D; Krummen M Curr Med Res Opin; 2007 Oct; 23(10):2405-13. PubMed ID: 20350055 [TBL] [Abstract][Full Text] [Related]
20. The effect of budesonide and formoterol in one pressurized metered-dose inhaler on patient-reported outcomes in adults with mild-to-moderate persistent asthma. Murphy K; Nelson H; Parasuraman B; Boggs R; Miller C; O'Dowd L Curr Med Res Opin; 2008 Mar; 24(3):879-94. PubMed ID: 18267051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]